Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

Purpose Several hundred genetic muscle diseases have been described, all of which are rare. Their clinical and genetic heterogeneity means that a genetic diagnosis is challenging. We established an international consortium, MYO-SEQ, to aid the work-ups of muscle disease patients and to better unders...

Descripción completa

Detalles Bibliográficos
Autores: Topf, A, Johnson, K, Bates, A, Phillips, L, Chao, KR, England, EM, Laricchia, KM, Mullen, T, Valkanas, E, Xu, LW, Bertoli, M, Blain, A, Casasus, AB, Duff, J, Mroczek, M, Specht, S, Lek, M, Ensini, M, MacArthur, DG, Straub, V, Alonso-Pérez J., González-Quereda L.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p6184
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6184
Access Level:acceso abierto
Palabra clave:next-generation sequencing
targeted exome analysis
neuromuscular disease
limb-girdle weakness
genetic diagnosis
id ES_b2d768398f8aebc2ec6ab0463a70eaf9
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p6184
network_acronym_str ES
network_name_str España
repository_id_str
spelling Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weaknessTopf, AJohnson, KBates, APhillips, LChao, KREngland, EMLaricchia, KMMullen, TValkanas, EXu, LWBertoli, MBlain, ACasasus, ABDuff, JMroczek, MSpecht, SLek, MEnsini, MMacArthur, DGStraub, VAlonso-Pérez J.González-Quereda L.next-generation sequencingtargeted exome analysisneuromuscular diseaselimb-girdle weaknessgenetic diagnosisPurpose Several hundred genetic muscle diseases have been described, all of which are rare. Their clinical and genetic heterogeneity means that a genetic diagnosis is challenging. We established an international consortium, MYO-SEQ, to aid the work-ups of muscle disease patients and to better understand disease etiology. Methods Exome sequencing was applied to 1001 undiagnosed patients recruited from more than 40 neuromuscular disease referral centers; standardized phenotypic information was collected for each patient. Exomes were examined for variants in 429 genes associated with muscle conditions. Results We identified suspected pathogenic variants in 52% of patients across 87 genes. We detected 401 novel variants, 116 of which were recurrent. Variants inCAPN3,DYSF,ANO5,DMD,RYR1,TTN,COL6A2, andSGCAcollectively accounted for over half of the solved cases; while variants in newer disease genes, such asBVESandPOGLUT1, were also found. The remaining well-characterized unsolved patients (48%) need further investigation. Conclusion Using our unique infrastructure, we developed a pathway to expedite muscle disease diagnoses. Our data suggest that exome sequencing should be used for pathogenic variant detection in patients with suspected genetic muscle diseases, focusing first on the most common disease genes described here, and subsequently in rarer and newly characterized disease genes.SPRINGERNATURE2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6184GENETICS IN MEDICINEISSN: 10983600ISSNe: 15300366reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p61842026-06-14T12:41:47Z
dc.title.none.fl_str_mv Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
title Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
spellingShingle Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
Topf, A
next-generation sequencing
targeted exome analysis
neuromuscular disease
limb-girdle weakness
genetic diagnosis
title_short Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
title_full Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
title_fullStr Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
title_full_unstemmed Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
title_sort Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
dc.creator.none.fl_str_mv Topf, A
Johnson, K
Bates, A
Phillips, L
Chao, KR
England, EM
Laricchia, KM
Mullen, T
Valkanas, E
Xu, LW
Bertoli, M
Blain, A
Casasus, AB
Duff, J
Mroczek, M
Specht, S
Lek, M
Ensini, M
MacArthur, DG
Straub, V
Alonso-Pérez J.
González-Quereda L.
author Topf, A
author_facet Topf, A
Johnson, K
Bates, A
Phillips, L
Chao, KR
England, EM
Laricchia, KM
Mullen, T
Valkanas, E
Xu, LW
Bertoli, M
Blain, A
Casasus, AB
Duff, J
Mroczek, M
Specht, S
Lek, M
Ensini, M
MacArthur, DG
Straub, V
Alonso-Pérez J.
González-Quereda L.
author_role author
author2 Johnson, K
Bates, A
Phillips, L
Chao, KR
England, EM
Laricchia, KM
Mullen, T
Valkanas, E
Xu, LW
Bertoli, M
Blain, A
Casasus, AB
Duff, J
Mroczek, M
Specht, S
Lek, M
Ensini, M
MacArthur, DG
Straub, V
Alonso-Pérez J.
González-Quereda L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv next-generation sequencing
targeted exome analysis
neuromuscular disease
limb-girdle weakness
genetic diagnosis
topic next-generation sequencing
targeted exome analysis
neuromuscular disease
limb-girdle weakness
genetic diagnosis
description Purpose Several hundred genetic muscle diseases have been described, all of which are rare. Their clinical and genetic heterogeneity means that a genetic diagnosis is challenging. We established an international consortium, MYO-SEQ, to aid the work-ups of muscle disease patients and to better understand disease etiology. Methods Exome sequencing was applied to 1001 undiagnosed patients recruited from more than 40 neuromuscular disease referral centers; standardized phenotypic information was collected for each patient. Exomes were examined for variants in 429 genes associated with muscle conditions. Results We identified suspected pathogenic variants in 52% of patients across 87 genes. We detected 401 novel variants, 116 of which were recurrent. Variants inCAPN3,DYSF,ANO5,DMD,RYR1,TTN,COL6A2, andSGCAcollectively accounted for over half of the solved cases; while variants in newer disease genes, such asBVESandPOGLUT1, were also found. The remaining well-characterized unsolved patients (48%) need further investigation. Conclusion Using our unique infrastructure, we developed a pathway to expedite muscle disease diagnoses. Our data suggest that exome sequencing should be used for pathogenic variant detection in patients with suspected genetic muscle diseases, focusing first on the most common disease genes described here, and subsequently in rarer and newly characterized disease genes.
publishDate 2020
dc.date.none.fl_str_mv 2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6184
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6184
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv SPRINGERNATURE
publisher.none.fl_str_mv SPRINGERNATURE
dc.source.none.fl_str_mv GENETICS IN MEDICINE
ISSN: 10983600
ISSNe: 15300366
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417088489095168
score 15,812455